INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 169 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $377,546 | +111270.5% | 33,800 | +34.2% | 0.00% | – |
| Q1 2023 | $339 | -99.9% | 25,182 | -29.5% | 0.00% | -100.0% |
| Q3 2022 | $586,000 | +31.1% | 35,700 | +9.2% | 0.00% | – |
| Q2 2022 | $447,000 | -13.7% | 32,700 | +2.5% | 0.00% | – |
| Q1 2022 | $518,000 | -43.1% | 31,900 | -42.8% | 0.00% | -100.0% |
| Q4 2021 | $911,000 | -4.4% | 55,800 | -11.1% | 0.00% | 0.0% |
| Q3 2021 | $953,000 | +4.2% | 62,800 | +44.7% | 0.00% | -50.0% |
| Q2 2021 | $915,000 | +17.2% | 43,400 | +25.8% | 0.00% | 0.0% |
| Q1 2021 | $781,000 | -49.1% | 34,500 | -42.5% | 0.00% | 0.0% |
| Q4 2020 | $1,535,000 | -42.6% | 60,000 | -6.2% | 0.00% | -71.4% |
| Q3 2020 | $2,672,000 | -23.0% | 63,965 | -13.9% | 0.01% | -22.2% |
| Q2 2020 | $3,471,000 | -39.3% | 74,326 | -15.5% | 0.01% | -47.1% |
| Q1 2020 | $5,721,000 | -73.4% | 87,962 | -49.6% | 0.02% | -67.9% |
| Q4 2019 | $21,529,000 | +77.7% | 174,416 | -7.7% | 0.05% | +51.4% |
| Q3 2019 | $12,115,000 | -16.5% | 188,944 | +3.6% | 0.04% | -14.6% |
| Q2 2019 | $14,517,000 | -46.7% | 182,458 | -25.1% | 0.04% | -48.8% |
| Q1 2019 | $27,260,000 | +41.3% | 243,704 | +18.8% | 0.08% | +48.1% |
| Q4 2018 | $19,290,000 | -14.2% | 205,105 | +15.3% | 0.05% | +8.0% |
| Q3 2018 | $22,472,000 | +172.3% | 177,840 | +32.6% | 0.05% | +150.0% |
| Q2 2018 | $8,253,000 | 0.0% | 134,162 | 0.0% | 0.02% | 0.0% |
| Q1 2018 | $8,253,000 | -40.9% | 134,162 | +17.9% | 0.02% | -68.8% |
| Q2 2017 | $13,972,000 | +20.5% | 113,835 | +10.9% | 0.06% | 0.0% |
| Q1 2017 | $11,591,000 | -30.2% | 102,685 | -32.8% | 0.06% | -22.0% |
| Q4 2016 | $16,613,000 | -23.0% | 152,900 | +13.6% | 0.08% | -18.8% |
| Q3 2016 | $21,566,000 | +23.0% | 134,600 | +15.0% | 0.10% | +2.0% |
| Q2 2016 | $17,535,000 | – | 117,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
| Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
| Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
| Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
| Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
| BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
| ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
| FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |